A multi-institutional feasibility study on the use of automated screening systems for quality control rescreening of cervical cytology

Yuko Sugiyama, Hiroshi Sasaki, Kyoko Komatsu, Ryuji Yabushita, Mizue Oda, Kenji Yanoh, Masatsugu Ueda, Hiroaki Itamochi, Kaoru Okugawa, Hiromasa Fujita, Toru Tase, Eiji Nakatani, Takuya Moriya

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate the efficacy of the automated screening system FocalPoint for cervical cytology quality control (QC) rescreening. False-negative rates (FNRs) were evaluated by a multi-institutional retrospective study. Study Design: Cervical cytology slides that had already been reported as negative for intraepithelial lesion or malignancy (NILM) were chosen arbitrarily for FocalPoint rescreening. Slides stratified into the highest 15% probability of being abnormal were rescreened by a cytotechnologist. The slides that were abnormal were reevaluated by a cytopathologist to be false negatives. Results: Rescreening of 12,000 slides, i.e. 9,000 conventional slides and 3,000 liquid-based cytology (LBC) slides, was performed; 9,826 (7,393 conventional and 2,433 LBC) were satisfactory for FocalPoint (2,174 were determined unsatisfactory) and those within the highest 15% of probability (1,496, i.e. 1,123 conventional and 373 LBC) were rescreened. As a result, 117 (96 conventional and 21 LBC) were determined as abnormal (other than NILM) and the FNR was 1.19%. Among these 117 slides, 40 (35 conventional and 5 LBC) were determined as high-grade squamous intraepithelial lesion and greater (HSIL+). Conclusion: Of 117 (1.19%) abnormal slides detected, 40 (0.41%) were determined to be HSIL+. This result suggests that FocalPoint is effective for QC rescreening of cervical cytology.

Original languageEnglish
Pages (from-to)451-457
Number of pages7
JournalActa Cytologica
Volume60
Issue number5
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Feasibility Studies
Quality Control
Cell Biology
Neoplasms
Retrospective Studies

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Histology

Cite this

A multi-institutional feasibility study on the use of automated screening systems for quality control rescreening of cervical cytology. / Sugiyama, Yuko; Sasaki, Hiroshi; Komatsu, Kyoko; Yabushita, Ryuji; Oda, Mizue; Yanoh, Kenji; Ueda, Masatsugu; Itamochi, Hiroaki; Okugawa, Kaoru; Fujita, Hiromasa; Tase, Toru; Nakatani, Eiji; Moriya, Takuya.

In: Acta Cytologica, Vol. 60, No. 5, 01.11.2016, p. 451-457.

Research output: Contribution to journalArticle

Sugiyama, Y, Sasaki, H, Komatsu, K, Yabushita, R, Oda, M, Yanoh, K, Ueda, M, Itamochi, H, Okugawa, K, Fujita, H, Tase, T, Nakatani, E & Moriya, T 2016, 'A multi-institutional feasibility study on the use of automated screening systems for quality control rescreening of cervical cytology', Acta Cytologica, vol. 60, no. 5, pp. 451-457. https://doi.org/10.1159/000449499
Sugiyama, Yuko ; Sasaki, Hiroshi ; Komatsu, Kyoko ; Yabushita, Ryuji ; Oda, Mizue ; Yanoh, Kenji ; Ueda, Masatsugu ; Itamochi, Hiroaki ; Okugawa, Kaoru ; Fujita, Hiromasa ; Tase, Toru ; Nakatani, Eiji ; Moriya, Takuya. / A multi-institutional feasibility study on the use of automated screening systems for quality control rescreening of cervical cytology. In: Acta Cytologica. 2016 ; Vol. 60, No. 5. pp. 451-457.
@article{4d586dc980774a9c9a7c112b76af297d,
title = "A multi-institutional feasibility study on the use of automated screening systems for quality control rescreening of cervical cytology",
abstract = "Objective: To evaluate the efficacy of the automated screening system FocalPoint for cervical cytology quality control (QC) rescreening. False-negative rates (FNRs) were evaluated by a multi-institutional retrospective study. Study Design: Cervical cytology slides that had already been reported as negative for intraepithelial lesion or malignancy (NILM) were chosen arbitrarily for FocalPoint rescreening. Slides stratified into the highest 15{\%} probability of being abnormal were rescreened by a cytotechnologist. The slides that were abnormal were reevaluated by a cytopathologist to be false negatives. Results: Rescreening of 12,000 slides, i.e. 9,000 conventional slides and 3,000 liquid-based cytology (LBC) slides, was performed; 9,826 (7,393 conventional and 2,433 LBC) were satisfactory for FocalPoint (2,174 were determined unsatisfactory) and those within the highest 15{\%} of probability (1,496, i.e. 1,123 conventional and 373 LBC) were rescreened. As a result, 117 (96 conventional and 21 LBC) were determined as abnormal (other than NILM) and the FNR was 1.19{\%}. Among these 117 slides, 40 (35 conventional and 5 LBC) were determined as high-grade squamous intraepithelial lesion and greater (HSIL+). Conclusion: Of 117 (1.19{\%}) abnormal slides detected, 40 (0.41{\%}) were determined to be HSIL+. This result suggests that FocalPoint is effective for QC rescreening of cervical cytology.",
author = "Yuko Sugiyama and Hiroshi Sasaki and Kyoko Komatsu and Ryuji Yabushita and Mizue Oda and Kenji Yanoh and Masatsugu Ueda and Hiroaki Itamochi and Kaoru Okugawa and Hiromasa Fujita and Toru Tase and Eiji Nakatani and Takuya Moriya",
year = "2016",
month = "11",
day = "1",
doi = "10.1159/000449499",
language = "English",
volume = "60",
pages = "451--457",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",
number = "5",

}

TY - JOUR

T1 - A multi-institutional feasibility study on the use of automated screening systems for quality control rescreening of cervical cytology

AU - Sugiyama, Yuko

AU - Sasaki, Hiroshi

AU - Komatsu, Kyoko

AU - Yabushita, Ryuji

AU - Oda, Mizue

AU - Yanoh, Kenji

AU - Ueda, Masatsugu

AU - Itamochi, Hiroaki

AU - Okugawa, Kaoru

AU - Fujita, Hiromasa

AU - Tase, Toru

AU - Nakatani, Eiji

AU - Moriya, Takuya

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Objective: To evaluate the efficacy of the automated screening system FocalPoint for cervical cytology quality control (QC) rescreening. False-negative rates (FNRs) were evaluated by a multi-institutional retrospective study. Study Design: Cervical cytology slides that had already been reported as negative for intraepithelial lesion or malignancy (NILM) were chosen arbitrarily for FocalPoint rescreening. Slides stratified into the highest 15% probability of being abnormal were rescreened by a cytotechnologist. The slides that were abnormal were reevaluated by a cytopathologist to be false negatives. Results: Rescreening of 12,000 slides, i.e. 9,000 conventional slides and 3,000 liquid-based cytology (LBC) slides, was performed; 9,826 (7,393 conventional and 2,433 LBC) were satisfactory for FocalPoint (2,174 were determined unsatisfactory) and those within the highest 15% of probability (1,496, i.e. 1,123 conventional and 373 LBC) were rescreened. As a result, 117 (96 conventional and 21 LBC) were determined as abnormal (other than NILM) and the FNR was 1.19%. Among these 117 slides, 40 (35 conventional and 5 LBC) were determined as high-grade squamous intraepithelial lesion and greater (HSIL+). Conclusion: Of 117 (1.19%) abnormal slides detected, 40 (0.41%) were determined to be HSIL+. This result suggests that FocalPoint is effective for QC rescreening of cervical cytology.

AB - Objective: To evaluate the efficacy of the automated screening system FocalPoint for cervical cytology quality control (QC) rescreening. False-negative rates (FNRs) were evaluated by a multi-institutional retrospective study. Study Design: Cervical cytology slides that had already been reported as negative for intraepithelial lesion or malignancy (NILM) were chosen arbitrarily for FocalPoint rescreening. Slides stratified into the highest 15% probability of being abnormal were rescreened by a cytotechnologist. The slides that were abnormal were reevaluated by a cytopathologist to be false negatives. Results: Rescreening of 12,000 slides, i.e. 9,000 conventional slides and 3,000 liquid-based cytology (LBC) slides, was performed; 9,826 (7,393 conventional and 2,433 LBC) were satisfactory for FocalPoint (2,174 were determined unsatisfactory) and those within the highest 15% of probability (1,496, i.e. 1,123 conventional and 373 LBC) were rescreened. As a result, 117 (96 conventional and 21 LBC) were determined as abnormal (other than NILM) and the FNR was 1.19%. Among these 117 slides, 40 (35 conventional and 5 LBC) were determined as high-grade squamous intraepithelial lesion and greater (HSIL+). Conclusion: Of 117 (1.19%) abnormal slides detected, 40 (0.41%) were determined to be HSIL+. This result suggests that FocalPoint is effective for QC rescreening of cervical cytology.

UR - http://www.scopus.com/inward/record.url?scp=84989271341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989271341&partnerID=8YFLogxK

U2 - 10.1159/000449499

DO - 10.1159/000449499

M3 - Article

C2 - 27673689

AN - SCOPUS:84989271341

VL - 60

SP - 451

EP - 457

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

IS - 5

ER -